aspenpharma.com

Webbplats analys aspenpharma.com

Aspen Pharmacare | Pharmaceutical Company

 Genereras på Mars 12 2026 17:36 PM

Gammal statistik? UPDATERA !

Ställningen är 57/100

SEO Innehåll

Titel

Aspen Pharmacare | Pharmaceutical Company

Längd : 41

Perfekt, din titel innehåller mellan 10 och 70 tecken.

Beskrivning

Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets

Längd : 131

Bra, din metabeskrivning innehåller mellan 70 och 160 tecken.

Nyckelord

Mycket dåligt. Vi har inte lyckats hitta några meta-taggar på din sida. Använd denna meta-tag generator, gratis för att skapa nyckelord.

Og Meta Egenskaper

Bra, din sida drar nytta utav Og.

Egendom Innehåll
locale en_US
type website
title Aspen Pharmacare | Pharmaceutical Company
description Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets
url https://www.aspenpharma.com/
site_name Aspen Pharmacare
image https://www.aspenpharma.com/wp-content/uploads/2023/02/aspen-pharma-vials-home-1.png
image:width 496
image:height 656
image:type image/png

Rubriker

H1 H2 H3 H4 H5 H6
0 62 65 10 60 30
  • [H2] Aspen delivers encouraging results, driven by strong Commercial Pharma, reshaped Manufacturing and value realisation from APAC divestment
  • [H2] Proposed divestment of Aspen Asia Pacific (excluding China) for R26.5 billion
  • [H2] Stephen Saad receives both AABLA Lifetime Achievement Award and African of the Year Award
  • [H2] Aspen highlights the rising diabetes disease burden
  • [H2] Aspen building momentum in Commercial Pharmaceuticals and Manufacturing strategy modified
  • [H2] Aspen celebrates 15 years of commitment to Nelson Mandela Day
  • [H2] Aspen delivers strong results and advances its strategic ambitions
  • [H2] Aspen announces local availability of Lilly’s Mounjaro
  • [H2] Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day
  • [H2] Aspen to participate in the Investec CEO conference in London
  • [H2] Aspen partners with PinkDrive to mobilise cancer screening
  • [H2] Aspen’s revenue increases 10% underpinned by a strong second half performance
  • [H2] Aspen delivers encouraging results, driven by strong Commercial Pharma, reshaped Manufacturing and value realisation from APAC divestment
  • [H2] Proposed divestment of Aspen Asia Pacific (excluding China) for R26.5 billion
  • [H2] Stephen Saad receives both AABLA Lifetime Achievement Award and African of the Year Award
  • [H2] Aspen highlights the rising diabetes disease burden
  • [H2] Aspen building momentum in Commercial Pharmaceuticals and Manufacturing strategy modified
  • [H2] Aspen celebrates 15 years of commitment to Nelson Mandela Day
  • [H2] Aspen delivers strong results and advances its strategic ambitions
  • [H2] Aspen announces local availability of Lilly’s Mounjaro
  • [H2] Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day
  • [H2] Aspen to participate in the Investec CEO conference in London
  • [H2] Aspen partners with PinkDrive to mobilise cancer screening
  • [H2] Aspen’s revenue increases 10% underpinned by a strong second half performance
  • [H2] Healthcare. We Care.
  • [H2] Investor Hub
  • [H2] Stephen Saad (61)
  • [H2] Sean Capazorio (60)
  • [H2] Reginald Haman (52)
  • [H2] Kuseni Dlamini 58
  • [H2] Ben Kruger (66)
  • [H2] Linda de Beer (56)
  • [H2] Neo Dongwana (53)
  • [H2] Themba Mkhwanazi (56)
  • [H2] Chris Mortimer (65)
  • [H2] Yvonne Muthien (69)
  • [H2] David Redfern (59)*
  • [H2] Raeesa Khan (35)
  • [H2] Stephen Saad (61)
  • [H2] Gus Attridge (64)
  • [H2] Sean Capazorio (60)
  • [H2] Lorraine Hill (62)
  • [H2] Reginald Haman (51)
  • [H2] Samer Kassem (51)
  • [H2] Pauline Macdonald (49)
  • [H2] Trevor Ziman (54)
  • [H2] Chris Botha (47)
  • [H2] Raeesa Khan (35)
  • [H2] Stavros Nicolaou (60)
  • [H2] Carnie van der Linde (56)
  • [H2] Aspen Key Facts
  • [H2] Latest News
  • [H2] Our Purpose
  • [H2] Our Vision
  • [H2] Our Values
  • [H2] About Aspen
  • [H2] We Care
  • [H2] Careers
  • [H2] Contact Us
  • [H2] Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026. The live presentation will take place in Cape Town at 08h30 on 2 March 2023.
  • [H2] Corporate
  • [H2] View our teams below:
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.
  • [H3] Healthcare. We Care. Excellence Integrity Healthcare. We Care. Innovation Commitment Teamwork
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] FY2026 Interim Results Booklet
  • [H3] FY2026 Interim Results Short Form Announcement
  • [H3] Our Heritage
  • [H3] Fact Sheet
  • [H3] Interim Results Presentation
  • [H3] Illustrative Revenue Disclosure
  • [H3] Interim Results Booklet
  • [H3] Interim Results Booklet – Excel Download
  • [H3] Interim Results Presentation Webcast
  • [H3] Interim Results Short Form Announcement
  • [H3] Stakeholder Update Call Presentation 15 January 2026
  • [H3] Stakeholder Update Call Webcast 15 January 2026
  • [H3] Sustainability and ESG Data Supplement
  • [H3] Social and Ethics Committee Report
  • [H3] Notice of AGM
  • [H3] Integrated Report
  • [H3] Audit & Risk Committee Report
  • [H3] Integrated Report – View Online Version
  • [H3] Carbon Disclosure Project – Climate Change and Water Security
  • [H3] Equity Report – Pharmacare Workforce Profile
  • [H3] IBIS Assurance Statement
  • [H3] Sustainability and ESG Data Supplement
  • [H3] Sustainability Materiality Assessment
  • [H3] Aspen delivers encouraging results, driven by strong Commercial Pharma, reshaped Manufacturing and value realisation from APAC divestment
  • [H3] Proposed divestment of Aspen Asia Pacific (excluding China) for R26.5 billion
  • [H3] Stephen Saad receives both AABLA Lifetime Achievement Award and African of the Year Award
  • [H3] Aspen highlights the rising diabetes disease burden
  • [H3] Aspen building momentum in Commercial Pharmaceuticals and Manufacturing strategy modified
  • [H3] Aspen celebrates 15 years of commitment to Nelson Mandela Day
  • [H3] Aspen delivers strong results and advances its strategic ambitions
  • [H3] Aspen announces local availability of Lilly’s Mounjaro
  • [H3] Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day
  • [H3] Aspen to participate in the Investec CEO conference in London
  • [H3] Aspen Ireland gets recognised for their efforts in diversity
  • [H3] Shining the spotlight on trailblazers in Science this International Women’s Day
  • [H3] Aspen North America Region’s Aspen Canada certified as a Great Place to Work®
  • [H3] Aspen continues to demonstrate its unwavering commitment to our various communities
  • [H3] Aspen partners with Reach for a Dream to bring joy to children with rare diseases 
  • [H3] Aspen launches its 2025 Integrated Report and retains Level 4 B-BBEE status
  • [H3] Aspen recognised for EY Excellence in Integrated Reporting Award
  • [H3] Closed Period
  • [H4] Board of Directors
  • [H4] Group Executive Committee
  • [H4] Financial Results
  • [H4] Integrated Reporting
  • [H4] Sustainability Documents
  • [H4] Interim Results
  • [H4] Additional Presentations and webcasts
  • [H4]  
  • [H4] Annual Financial Statements
  • [H4] Access to Medicines Position Paper
  • [H5] About Aspen
  • [H5] Corporate Governance
  • [H5] Regional Overview
  • [H5] Business Segments
  • [H5] Manufacturing
  • [H5] Investor Relations
  • [H5] Investor Relations
  • [H5] We Care
  • [H5] Ethics & Compliance Management
  • [H5] SED Initiatives
  • [H5] Mandela Day
  • [H5] Our Sustainability Commitments
  • [H5] Careers
  • [H5] High Performing, Inclusive Culture
  • [H5] Working At Aspen
  • [H5] Bursary Applications
  • [H5] Media
  • [H5] Aspen Holding News
  • [H5] About Aspen
  • [H5] Corporate Governance
  • [H5] Regional Overview
  • [H5] Business Segments
  • [H5] Manufacturing
  • [H5] Investor Relations
  • [H5] Investor Relations
  • [H5] We Care
  • [H5] Ethics & Compliance Management
  • [H5] SED Initiatives
  • [H5] Mandela Day
  • [H5] Our Sustainability Commitments
  • [H5] Careers
  • [H5] High Performing, Inclusive Culture
  • [H5] Working At Aspen
  • [H5] Bursary Applications
  • [H5] Media
  • [H5] Aspen Holding News
  • [H5] Stephen Saad(61)
  • [H5] Sean Capazorio(60)
  • [H5] Reginald Haman(52)
  • [H5] Kuseni Dlamini(58)
  • [H5] Ben Kruger(66)
  • [H5] Linda de Beer(56)
  • [H5] Neo Dongwana(53)
  • [H5] Themba Mkhwanazi(56)
  • [H5] Chris Mortimer(65)
  • [H5] Yvonne Muthien(69)
  • [H5] David Redfern(59)
  • [H5] Raeesa Khan(35)
  • [H5] Stephen Saad(61)
  • [H5] Gus Attridge(64)
  • [H5] Sean Capazorio(60)
  • [H5] Lorraine Hill(62)
  • [H5] Reginald Haman(52)
  • [H5] Samer Kassem(51)
  • [H5] Pauline Macdonald(49)
  • [H5] Trevor Ziman(54)
  • [H5] Chris Botha(47)
  • [H5] Raeesa Khan(35)
  • [H5] Stavros Nicolaou(60)
  • [H5] Carnie van der Linde(56)
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Further Information
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Further Information
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Find out more
  • [H6] To improve the health and quality of life of patients.
  • [H6] Find out more
  • [H6] To deliver value to all our stakeholders as a responsible corporate citizen that provides high-quality, affordable medicines globally.
  • [H6] Find out more
  • [H6] Define the foundation on which Aspen has been built. These are the values we share as we work together toward achieving the vision of the Group.

Bilder

Vi hittade 91 bilder på denna webbsida.

51 alt attribut är tomma eller saknas. Lägg till alternativ text så att sökmotorer enklare kan förstå innehållet i dina bilder.

Text/HTML Ratio

Ratio : 13%

Denna sidas förhållande mellan text till HTML-kod är lägre än 15 procent, vilket innebär att din webbplats troligen behöver mer textinnehåll.

Flash

Perfekt, inga Flash-innehåll har upptäckts på denna sida.

Iframe

Bra, vi upptäckte inga Iframes på den här sidan.

URL Rewrite

Bra. Dina adressfält ser bra ut!

Understreck i URLen

Perfekt! Inga understreck upptäcktes i din webbadress.

In-page länkar

Vi hittade totalt 92 länkar inklusive 0 länk(ar) till filer

Anchor Typ Juice
About Aspen Interna Passing Juice
Corporate Governance Interna Passing Juice
Regional Overview Interna Passing Juice
Manufacturing Interna Passing Juice
Interim Results Presentation Webcast Interna Passing Juice
FY2026 Interim Results Presentation Interna Passing Juice
Investor Relations Interna Passing Juice
Careers Interna Passing Juice
Aspen Holding News Interna Passing Juice
Aspen delivers encouraging results, driven by strong Commercial Pharma, reshaped Manufacturing and value realisation from APAC divestment Interna Passing Juice
Proposed divestment of Aspen Asia Pacific (excluding China) for R26.5 billion Interna Passing Juice
Stephen Saad receives both AABLA Lifetime Achievement Award and African of the Year Award Interna Passing Juice
Aspen highlights the rising diabetes disease burden Interna Passing Juice
Aspen building momentum in Commercial Pharmaceuticals and Manufacturing strategy modified Interna Passing Juice
Aspen celebrates 15 years of commitment to Nelson Mandela Day Interna Passing Juice
Aspen delivers strong results and advances its strategic ambitions Interna Passing Juice
Aspen announces local availability of Lilly’s Mounjaro Interna Passing Juice
Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day Interna Passing Juice
Aspen to participate in the Investec CEO conference in London Interna Passing Juice
Aspen partners with PinkDrive to mobilise cancer screening Interna Passing Juice
Aspen’s revenue increases 10% underpinned by a strong second half performance Interna Passing Juice
Contact Us Interna Passing Juice
FY2026 Interim Results Booklet Interna Passing Juice
FY2026 Interim Results Short Form Announcement Interna Passing Juice
Fact Sheet Interna Passing Juice
Interim Results Presentation Interna Passing Juice
Illustrative Revenue Disclosure Interna Passing Juice
Interim Results Booklet Interna Passing Juice
Interim Results Booklet – Excel Download Interna Passing Juice
Interim Results Presentation Webcast Interna Passing Juice
Interim Results Short Form Announcement Interna Passing Juice
Stakeholder Update Call Presentation 15 January 2026 Interna Passing Juice
Stakeholder Update Call Webcast 15 January 2026 Interna Passing Juice
Annual Financial Statements Interna Passing Juice
Sustainability and ESG Data Supplement Interna Passing Juice
Social and Ethics Committee Report Interna Passing Juice
Notice of AGM Interna Passing Juice
Integrated Report Interna Passing Juice
Audit & Risk Committee Report Interna Passing Juice
Integrated Report – View Online Version Interna Passing Juice
Access to Medicines Position Paper Interna Passing Juice
Carbon Disclosure Project – Climate Change and Water Security Interna Passing Juice
Equity Report – Pharmacare Workforce Profile Interna Passing Juice
IBIS Assurance Statement Interna Passing Juice
Sustainability Materiality Assessment Interna Passing Juice
Aspen Ireland gets recognised for their efforts in diversity Interna Passing Juice
Shining the spotlight on trailblazers in Science this International Women’s Day Interna Passing Juice
Aspen North America Region’s Aspen Canada certified as a Great Place to Work® Interna Passing Juice
Aspen continues to demonstrate its unwavering commitment to our various communities Interna Passing Juice
Aspen partners with Reach for a Dream to bring joy to children with rare diseases  Interna Passing Juice
Aspen launches its 2025 Integrated Report and retains Level 4 B-BBEE status Interna Passing Juice
Aspen recognised for EY Excellence in Integrated Reporting Award Interna Passing Juice
Disclaimer Interna Passing Juice
General Privacy Notice Externa Passing Juice
Aspen PAIA & POPI Manual Externa Passing Juice
Standard Terms of purchase of goods or services (STC) Externa Passing Juice
Australia Interna Passing Juice
China Externa Passing Juice
New Zealand Externa Passing Juice
Philippines Externa Passing Juice
Austria Externa Passing Juice
France Externa Passing Juice
France – NDB Externa Passing Juice
Netherlands Externa Passing Juice
Netherlands – Oss Externa Passing Juice
Russia Externa Passing Juice
Spain Externa Passing Juice
Switzerland Externa Passing Juice
MENAT Externa Passing Juice
Canada Externa Passing Juice
USA Externa Passing Juice
Brazil Interna Passing Juice
Mexico Externa Passing Juice
Ghana Externa Passing Juice
Kenya Externa Passing Juice
Mauritius Externa Passing Juice
Nigeria Externa Passing Juice
South Africa – SA Commercial Externa Passing Juice
South Africa – FCC Externa Passing Juice
South Africa HQ Externa Passing Juice
Tanzania Externa Passing Juice
EME Externa Passing Juice
France Externa Passing Juice
Germany Externa Passing Juice
Human Capital Interna Passing Juice
Legal Interna Passing Juice
Supply Chain Interna Passing Juice
Treasury Interna Passing Juice
Ethics & Compliance Interna Passing Juice
Risk & Sustainability Interna Passing Juice
Digital Technology Interna Passing Juice
Tax Interna Passing Juice

SEO Nyckelord

Nyckelord Moln

classification group aspen executive appointed more read results business qualifications

Nyckelord Konsistens

Nyckelord Innehåll Titel Nyckelord Beskrivning Rubriker
aspen 61
group 41
more 35
appointed 29
read 27

Användbarhet

Url

Domän : aspenpharma.com

Längd : 15

Favikon

Bra, din webbplats har en favicon.

Utskriftbart

Bra. Vi hittade CSS för utskrifter.

Språk

Bra. Ditt angivna språk är en.

Dublin Core

Denna sida drar inte nytta utav Dublin Core.

Dokument

Doctype

HTML 5

Encoding

Perfekt. Din deklarerade teckenuppsättning är UTF-8.

W3C Validity

Errors : 0

Varningar : 0

E-post Sekretess

Bra! Ingen e-postadress har hittats i klartext.

Föråldrad HTML

Bra! Vi har inte hittat några föråldrad HTML taggar i din HTML.

Hastighets Tips

Utmärkt, din webbplats använder inga nästlade tabeller.
Synd, din webbplats använder sig utav inline stilar.
Synd, din webbplats har för många CSS-filer (fler än 4 stycken).
Synd, din webbplats har för många JS filer (fler än 6 stycken).
Perfekt, din webbplats utnyttjar gzip.

Mobil

Mobiloptimering

Apple Ikon
Meta Viewport Tagg
Flash innehåll

Optimering

XML Sitemap

Bra, din webbplats har en XML sitemap.

https://www.aspenpharma.com/sitemap_index.xml

Robots.txt

https://aspenpharma.com/robots.txt

Bra, din webbplats har en robots.txt fil.

Analytics

Saknas

Vi hittade inte någon analysverktyg på din webbplats.

Webbanalys program kan mäta besökare på din webbplats. Du bör ha minst ett analysverktyg installerat, men det kan också vara en bra ide att installera två för att dubbelkolla uppgifterna.

PageSpeed Insights

Enhet
Kategorier

Free SEO Testing Tool

Free SEO Testing Tool är en fri SEO verktyg som hjälper dig att analysera din webbplats